Misplaced Pages

Talk:Biosafety level

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by MiszaBot I (talk | contribs) at 02:58, 4 December 2011 (Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 02:58, 4 December 2011 by MiszaBot I (talk | contribs) (Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
This is the talk page for discussing improvements to the Biosafety level article.
This is not a forum for general discussion of the article's subject.
Article policies
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL
Archives: 1Auto-archiving period: 14 days 
WikiProject iconMedicine C‑class Low‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Misplaced Pages talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
CThis article has been rated as C-class on Misplaced Pages's content assessment scale.
LowThis article has been rated as Low-importance on the project's importance scale.

Private BSL-3 facilities abound

Having worked and consulted in the DC area, RTP, Chicago, and at corporate sites around the eastern half of the US, I don't see any way to reasonably assemble a complete list of BSL-3 facilities. None of the ones I've worked at except USAMRIID are on this list; BSL-3 facilities are simply too common. Many vaccine manufacturing and testing facilities exist that can handle the pathogens requiring BSL-3, and most of them are not publicly advertised. The key point for BSL-3 is that treatment exists; if the treatment is derived from the living pathogen, industry will need this facility. While there isn't a West nile, Anthrax, SARS, or yellow fever testing facility on every corner, they are not uncommon enough to have the scarcity noted.

152.14.43.30 (talk) 16:51, 20 April 2011 (UTC) TWM

Similarly having worked in the UK industry designing such facilities, there are BSL-3 labs everywhere, and many, many are omitted from the list. BSL-4 is a different beast altogether and are much scarcer! --PopUpPirate (talk) 11:24, 3 September 2011 (UTC)

REDACTED

My apologies, I was wrong. Nevermind! Salvidrim (talk) 16:51, 21 August 2011 (UTC)

Noguchi Memorial Institute for Medical Research

Revision 456170207 by 197.255.96.5 (talk) added "Noguchi Memorial Institute for Medical Research" (NMIMR) to the External links section, but without any external link, citation, or indication of biosafety levels. I'm moving it to this talk page until the BSL can be confirmed.

The institute is in Ghana, is named after Hideyo Noguchi, and apparently has a BSL-2 or BSL-3 laboratory, or both. Some references:

85.23.32.64 (talk) 14:36, 20 November 2011 (UTC)

Missing BSL-3 Site

The Biosecurity Research Institute at Kansas State University in Manhattan Kansas has a BSL-3, ABSL-3 (animal BSL-3), BSL-3E (Enhanced BSL-3) and BSL-3Ag facility. It is located next to where the new BSL-4 facility is being built. It is mentioned in the article on the new facility but not listed as having its own BSL-3. This information was gleaned from a job posting on their website. So I assume it is reasonably accurate. DJBostrom (talk) 18:42, 3 December 2011 (UTC)

Categories: